Cargando…

Advances in Vasodilatory Shock: A Concise Review

Vasodilatory shock is a critical manifestation of cardiovascular failure. There is uncontrolled vasodilation and vascular hyporesponsiveness to endogenous vasoconstrictors, causing the failure of physiologic vasoregulatory mechanisms. Unfortunately, only few randomized studies exist to guide clinica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lahiry, Sandeep, Thakur, Sayanta, Chakraborty, Dwaipayan S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Jaypee Brothers Medical Publishers 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842826/ https://www.ncbi.nlm.nih.gov/pubmed/31749557 http://dx.doi.org/10.5005/jp-journals-10071-23266

Ejemplares similares

Effect of 1,25 dihydroxy vitamin D3 supplementation on pain relief in early rheumatoid arthritis
por: Mukherjee, Dibyendu, et al.
Publicado: (2019)

Osimertinib as an emerging therapeutic modality in nonsmall cell lung cancer: Opportunities and challenges in Indian scenario
por: Thakur, Sayanta, et al.
Publicado: (2020)

Digital clinical trial: A new norm in clinical research
por: Thakur, Sayanta, et al.
Publicado: (2021)

Past, Present, and Future of Remdesivir: An Overview of the Antiviral in Recent Times
por: Choudhury, Shouvik, et al.
Publicado: (2020)

Vasopressin in vasodilatory shock: is the heart in danger?
por: Hauser, Balázs, et al.
Publicado: (2008)

Vasopressin and terlipressin in adult vasodilatory shock
por: Polito, Angelo, et al.
Publicado: (2012)

Angiotensin II: a new therapeutic option for vasodilatory shock
por: Bussard, Rachel L, et al.
Publicado: (2018)

Daridorexant, a Recently Approved Dual Orexin Receptor Antagonists (DORA) in Treatment of Insomnia
por: Sarathi Chakraborty, Dwaipayan, et al.
Publicado: (2023)

Angiotensin II in vasodilatory shock: lights and shadows
por: Antonucci, Elio, et al.
Publicado: (2017)

How Effective is Angiotensin II in Decreasing Mortality of Vasodilatory Shock? A Systematic Review
por: Semedi, Bambang Pujo, et al.
Publicado: (2023)

Lefamulin, a recently approved novel antibacterial agent to fight against community-acquired bacterial pneumonia
por: Choudhury, Shouvik, et al.
Publicado: (2021)

Advances in orphan drug development: Time to change the status and stereotype
por: Thakur, Sayanta
Publicado: (2022)

Vasopressin for the treatment of vasodilatory shock: an ESICM systematic review and a meta-analysis
por: Polito, A, et al.
Publicado: (2011)

Vasopressin in vasodilatory shock: hemodynamic stabilization at the cost of the liver and the kidney?
por: Bracht, Hendrik, et al.
Publicado: (2007)

Risk factors for severe vasodilatory shock after cardiac surgery
por: Almeida, J, et al.
Publicado: (2015)

Vasopressin in pediatric vasodilatory shock: a multicentred randomized controlled trial
por: Choong, K, et al.
Publicado: (2009)

Refractory vasodilatory shock secondary to metformin overdose supported with VA ECMO()
por: Ives Tallman, Crystal, et al.
Publicado: (2021)

Efficacy and safety of methylene blue in patients with vasodilatory shock: A systematic review and meta-analysis
por: Zhao, Cong-Cong, et al.
Publicado: (2022)

Early norepinephrine decreases fluid and ventilatory requirements in pediatric vasodilatory septic shock
por: Ranjit, Suchitra, et al.
Publicado: (2016)

Vasopressin in vasodilatory shock: ensure organ blood flow, but take care of the heart!
por: Dünser, Martin W, et al.
Publicado: (2006)

Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock
por: Bellomo, Rinaldo, et al.
Publicado: (2020)

Methylene blue for vasodilatory shock in the intensive care unit: a retrospective, observational study
por: Naoum, Emily E., et al.
Publicado: (2022)

VASOPRESSOR-RESISTANT HYPOTENSION, COMBINATION VASOPRESSOR THERAPY, AND SHOCK PHENOTYPES IN CRITICALLY ILL ADULTS WITH VASODILATORY SHOCK
por: Priyanka, Priyanka, et al.
Publicado: (2022)

Angiotensin II infusion in COVID-19-associated vasodilatory shock: a case series
por: Zangrillo, Alberto, et al.
Publicado: (2020)

Non-Adrenergic Vasopressors in Patients with or at Risk for Vasodilatory Shock. A Systematic Review and Meta-Analysis of Randomized Trials
por: Belletti, Alessandro, et al.
Publicado: (2015)

Angiotensin II for the treatment of vasodilatory shock: enough data to consider angiotensin II safe?
por: Buchtele, Nina, et al.
Publicado: (2018)

Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II
por: Tumlin, James A., et al.
Publicado: (2018)

Gene Expression Scoring of Immune Activity Levels for Precision Use of Hydrocortisone in Vasodilatory Shock
por: Yao, Lijing, et al.
Publicado: (2022)

Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials
por: Serpa Neto, Ary, et al.
Publicado: (2012)

Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials
por: Pereira, VGM, et al.
Publicado: (2013)

"Vasopressor Support Sparing Strategies": a Concept to be Incorporated as a Paradigm in the Treatment of Vasodilatory Shock
por: Evora, Paulo Roberto B., et al.
Publicado: (2019)

Hyponatremia in a Patient With Vasodilatory Shock Due to Overdose of Antihypertensive Medications: A Case Report
por: Rasheed, Abdul Hannan A, et al.
Publicado: (2023)

Synthetic Human Angiotensin II in Pediatric Patients With Vasodilatory Shock: A Report on Two Patients
por: Bailey, Dwight M., et al.
Publicado: (2019)

Cutaneous vascular reactivity and flow motion response to vasopressin in advanced vasodilatory shock and severe postoperative multiple organ dysfunction syndrome
por: Luckner, Günter, et al.
Publicado: (2006)

A Paradoxical Vasodilatory Nutraceutical Intervention for Prevention and Attenuation of Migraine—A Hypothetical Review
por: Chaliha, Devahuti Rai, et al.
Publicado: (2020)

Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock. A Clinical Trial
por: Bellomo, Rinaldo, et al.
Publicado: (2020)

Aging impairs vasodilatory responses in rats
por: Kim, Soon Yul, et al.
Publicado: (2011)

Optimal target blood pressure in critically ill adult patients with vasodilatory shock: A systematic review and meta-analysis
por: Yoshimoto, Hidero, et al.
Publicado: (2022)

Sensitivity to angiotensin II dose in patients with vasodilatory shock: a prespecified analysis of the ATHOS-3 trial
por: Ham, Kealy R., et al.
Publicado: (2019)

Optimal target blood pressure in critically ill adult patients with vasodilatory shock: a protocol for a systematic review and meta-analysis
por: Fukui, Satoshi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c7r873ebndhqptdoerqhevgnnp